Sponsored by: Investment Center

Something new in your business?  Click here to submit your business press release

Chamber Corner | Main Street News | Job Hunt | Classifieds | Calendar | Illinois Lottery 

Johnson & Johnson buys 18 percent stake in Crucell

Send a link to a friend

[September 28, 2009]  AMSTERDAM (AP) -- U.S. health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in biotechnology company Crucell NV for euro301.8 million ($440 million), the Dutch company said in a statement Monday.

HardwareThe companies will collaborate on the development and marketing of vaccines and hope to create a "universal" flu vaccine, among other goals, Crucell said.

Crucell said the shares it is selling to Johnson & Johnson are newly created.

Crucell's shares were up 2.8 percent at euro16.395 in midday trading in Amsterdam.

[Associated Press]

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.



< Recent articles

Back to top


News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries

Community | Perspectives | Law & Courts | Leisure Time | Spiritual Life | Health & Fitness | Teen Scene
Calendar | Letters to the Editor